A.J. Rice

Stock Analyst at UBS

(4.22)
# 450
Out of 5,090 analysts
257
Total ratings
62.35%
Success rate
10.29%
Average return

Stocks Rated by A.J. Rice

Surgery Partners
Nov 13, 2025
Maintains: Buy
Price Target: $34$29
Current: $17.19
Upside: +68.70%
Aveanna Healthcare Holdings
Nov 7, 2025
Maintains: Neutral
Price Target: $9$9.5
Current: $9.31
Upside: +2.04%
AMN Healthcare Services
Nov 7, 2025
Maintains: Neutral
Price Target: $18$21
Current: $16.26
Upside: +26.08%
The Ensign Group
Nov 5, 2025
Maintains: Buy
Price Target: $205$220
Current: $177.97
Upside: +23.62%
Pediatrix Medical Group
Nov 5, 2025
Maintains: Neutral
Price Target: $17$23
Current: $22.12
Upside: +3.98%
Centene
Oct 30, 2025
Maintains: Neutral
Price Target: $31$42
Current: $38.34
Upside: +9.55%
Tenet Healthcare
Oct 29, 2025
Maintains: Buy
Price Target: $238$260
Current: $210.00
Upside: +23.81%
Universal Health Services
Oct 29, 2025
Maintains: Buy
Price Target: $280$302
Current: $231.08
Upside: +30.69%
BrightSpring Health Services
Oct 29, 2025
Maintains: Buy
Price Target: $35$42
Current: $35.79
Upside: +17.35%
Healthcare Services Group
Oct 28, 2025
Maintains: Buy
Price Target: $20$22
Current: $18.88
Upside: +16.53%
Maintains: Neutral
Price Target: $3.2$3.6
Current: $3.57
Upside: +0.84%
Maintains: Buy
Price Target: $88$95
Current: $75.90
Upside: +25.16%
Maintains: Buy
Price Target: $140$150
Current: $112.50
Upside: +33.33%
Initiates: Buy
Price Target: $17
Current: $8.79
Upside: +93.40%
Maintains: Buy
Price Target: $435$425
Current: $330.75
Upside: +28.50%
Initiates: Buy
Price Target: $145
Current: $113.19
Upside: +28.10%
Maintains: Neutral
Price Target: $10$8.5
Current: $9.33
Upside: -8.90%
Maintains: Neutral
Price Target: $15$14
Current: $14.91
Upside: -6.10%
Maintains: Neutral
Price Target: $19$17
Current: $8.00
Upside: +106.25%
Maintains: Neutral
Price Target: $80$68
Current: $69.28
Upside: -1.85%
Upgrades: Buy
Price Target: $38$40
Current: $29.89
Upside: +33.82%
Initiates: Buy
Price Target: $50
Current: $30.76
Upside: +62.55%
Maintains: Outperform
Price Target: $450$485
Current: $808.62
Upside: -40.02%
Reiterates: Outperform
Price Target: $95
Current: $15.47
Upside: +514.09%
Maintains: Outperform
Price Target: $311$316
Current: $486.70
Upside: -35.07%
Maintains: Outperform
Price Target: $125$96
Current: $75.63
Upside: +26.93%
Maintains: Outperform
Price Target: $635$575
Current: $257.85
Upside: +123.00%
Maintains: Outperform
Price Target: $590$610
Current: $330.91
Upside: +84.34%
Maintains: Outperform
Price Target: $308$305
Current: $258.39
Upside: +18.04%
Maintains: Neutral
Price Target: $64$79
Current: $198.83
Upside: -60.27%
Maintains: Outperform
Price Target: $350$410
Current: $151.86
Upside: +169.99%
Maintains: Neutral
Price Target: $43$37
Current: $2.59
Upside: +1,328.57%
Maintains: Neutral
Price Target: $158$143
Current: $182.51
Upside: -21.65%
Maintains: Outperform
Price Target: $300$270
Current: $265.44
Upside: +1.72%
Downgrades: Underperform
Price Target: $0.57
Current: $27.09
Upside: -97.90%